About
CNS Vital Signs develops computerized neurocognitive assessment software that measures brain function across multiple cognitive domains. The platform uses scientifically validated, objective tests to evaluate mental processes ranging from motor performance and attention to memory and executive function, alongside over 50 evidence-based clinical rating scales for symptoms, behaviors, and quality of life. The software auto-scores assessments immediately, eliminating variability and generating standardized reports with age-adjusted normative comparisons across a lifespan reference group from ages 8 to 89.
Clinicians use CNS Vital Signs as both a rapid screening tool and a deeper diagnostic instrument, deploying it across the care continuum to detect impairment, guide treatment decisions, track intervention outcomes, and monitor disease progression. The platform reveals neurocognitive abnormalities that often don't appear on imaging scans, such as in concussion cases, and identifies patterns of impairment useful for conditions including ADHD, mild cognitive impairment, mood disorders, chemo brain, and post-surgical recovery. The assessment is reimbursable, HIPAA and 21 CFR 11 compliant, and available through multiple delivery methods: local software on desktop or laptop, web-based testing, or remote administration from home or clinic.
The company operates on a straightforward model with no startup fees, service contracts, or mandatory software licensing. Assessments cost between $25 and $35 per test depending on the platform, with volume discounts available, and clinicians can configure custom test panels to match specific clinical needs.
Longevity Contribution
- Lifespan normative reference database spanning ages 8 to 89, enabling precise age-adjusted cognitive comparisons across the full human lifespan
- Embedded performance validity indicators that detect effort and reliability issues within the assessment itself
- Multi-platform delivery including local software, web-based, and remote testing with full integration across all modalities
- Sensitivity to detect neurocognitive impairment in the absence of positive CT or MRI findings, particularly valuable for concussion and subtle cognitive changes